While blocking the GCN2–ATF4 axis alone may exhibit a limited ability to reduce cancer cell growth, its blockade in conjunction with stress-inducing drug regimens could be a promising strategy to reduce cancer cell growth and invasion. This evidence concerns the gene ATF4 and cancer.